1
|
Effect of a 16-Session Qigong Program in Non-Hodgkin Lymphoma Survivors: A Randomized Clinical Trial. J Clin Med 2022; 11:jcm11123421. [PMID: 35743490 PMCID: PMC9225257 DOI: 10.3390/jcm11123421] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 05/30/2022] [Accepted: 06/10/2022] [Indexed: 12/04/2022] Open
Abstract
Background: The treatment associated with non-Hodgkin lymphoma patients may cause adverse effects on their physical and psychological condition. The aim of this study is to detect the response to an eight-week, 16-session, 60-min presential Qigong program in anxiety, depression and vagal nerve activity alongside a control group. Methods: A randomized controlled clinical trial was managed. Randomization was carried out by generating a numerical sequence of three cycles through the software EPIDAT 4.1. Numbers were placed in sealed opaque envelopes for assignment to the different groups. Results: Anxiety levels were substantially decreased in the experimental group, with a large effect size (F = 30.38, p < 0.00). Depression levels had an improvement in the experimental group in contrast to the control group, reaching statistical significance (F = 19.19, p < 0.00). Heart Rate Variability unveiled significant results in terms of between-group differences, with a large effect size in the HRV Index (F = 15.80, p < 0.00), SDNN (F = 8.82, p < 0.00), and RMSSD (F = 6.72, p < 0.01) in the time domain, and a medium effect size in the HF (F = 9.78, p < 0.003), LF (F = 9.78, p < 0.00), and LF/HF Ratio (F = 18.44, p < 0.00) in the frequency domain, which were all bettered in the experimental group, after the Qigong program. Conclusions: Qigong therapy can be an effective therapeutic activity in consonance with traditional medicine to improve psychological health and autonomic nervous system balance in non-Hodgkin lymphoma survivors.
Collapse
|
2
|
Lee HJ, Kim YA, Ryu SY, Chun M, Yim CY, Kang HT, Kang JH, Huh JS, Kim JH, Lim KH, Jung SY, Kwon HC, Goh E, Lee YS, Ju HY, Yun EH, Chang YJ. The Positive Effects of Cancer Survivor Support Service on Distress in South Korea: A Nationwide Prospective Study. Front Med (Lausanne) 2022; 9:769221. [PMID: 35237619 PMCID: PMC8882982 DOI: 10.3389/fmed.2022.769221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Accepted: 01/21/2022] [Indexed: 11/23/2022] Open
Abstract
Background and Aim Cancer survivors are gradually increasing, however, they suffer from various difficulties. We aimed to investigate the characteristics of cancer survivors and the effects of the services of the Korean Cancer Survivorship Center Pilot Project launched by the South Korean government on distress. Methods A prospective observational cohort study was performed on cancer survivors who completed primary treatment. Cancer survivors' distress and symptoms such as fatigue, pain, depressive mood, anxiety, and insomnia were evaluated by well-trained nurses. Regarding their needs, medical and psychosocial support services were provided. Results This study included 1,921 cancer survivors, with a mean age of 57.3 years (68.7% females). Breast cancer was most common, followed by stomach and colorectal cancer. Psychosocial and medical support decreased the percentage of the high-distress group from 50.9 to 30.5% and decreased the percentage of cancer survivors with high scores in fatigue, pain, anxiety, depressive mood, and insomnia. The independent predictors of a low distress level after the use of the services were older age, the relief of fatigue, pain, and insomnia. Conclusion This study showed that psychosocial and medical support is associated with the lower distress and physical and mental symptoms of cancer survivors. Psychosocial and medical support could contribute to distress relief in cancer survivors. Further management strategies for fatigue, pain and insomnia are required.
Collapse
Affiliation(s)
- Hyun Jeong Lee
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
- National Cancer Survivorship Center, National Cancer Center, Goyang, South Korea
- Department of Psychiatry and Behavioral Science, National Cancer Center, Goyang, South Korea
- Department of Psychiatry, Seoul National University, Seoul, South Korea
| | - Young Ae Kim
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
- National Cancer Survivorship Center, National Cancer Center, Goyang, South Korea
- *Correspondence: Young Ae Kim
| | - Seong Yeob Ryu
- Department of Surgery, Chonnam National University Medical School, Gwangju, South Korea
| | - Mison Chun
- Department of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea
| | - Chang-Yeol Yim
- Department of Internal Medicine, Chonbuk National University Medical School, Research Institute of Clinical Medicine of Chonbuk National University, Jeonju, South Korea
- Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, South Korea
| | - Hee-Taik Kang
- Department of Family Medicine, Chungbuk National University Hospital, Cheongju, South Korea
- Department of Family Medicine, Chungbuk National University College of Medicine, Cheongju, South Korea
| | - Jung Hun Kang
- Division of Hematology-Oncology, Department of Internal Medicine, College of Medicine, Gyeong-Sang National University, Jinju, South Korea
- Department of Medicine, Gyeongsang National University Hospital, Jinju, South Korea
| | - Jung-Sik Huh
- Department of Urology, School of Medicine, Jeju National University, Jeju, South Korea
| | - Jong-Heun Kim
- Department of Psychiatry and Behavioral Science, National Cancer Center, Goyang, South Korea
| | - Kyu-Hyoung Lim
- Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, South Korea
| | - So-Youn Jung
- Breast Cancer Center, National Cancer Center, Goyang, South Korea
| | - Hyoung-Cheol Kwon
- Department of Radiation Oncology, Chonbuk National University Hospital, Jeonju, South Korea
- Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute, Chonbuk National University Hospital, Jeonju, South Korea
- Department of Radiation Oncology, Chonbuk National University Medical School, Jeonju, South Korea
| | - Eurah Goh
- Department of Family Medicine, Postgraduate College of Medicine, Kangwon National University, Chuncheon, South Korea
| | - Yeon-Seung Lee
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
| | - Hee Young Ju
- Cancer Survivorship Branch, National Cancer Center, Goyang, South Korea
- Department of Pediatrics, Samsung Medical Center, Seoul, South Korea
| | - E. Hwa Yun
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
- National Cancer Survivorship Center, National Cancer Center, Goyang, South Korea
- Division of Cancer Registration and Surveillance, National Cancer Center, Goyang, South Korea
| | - Yoon Jung Chang
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
- National Cancer Survivorship Center, National Cancer Center, Goyang, South Korea
- Center for Cancer Prevention and Detection, National Cancer Center, Goyang, South Korea
- National Hospice Center, National Cancer Center, Goyang, South Korea
- Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, South Korea
| |
Collapse
|